Relation between estrogen receptor concentration and clinical and histological factors: Their relative prognostic importance after radical mastectomy for primary breast cancer

European Journal of Cancer and Clinical Oncology

Volumn 25, Issue 2, 1989, Pages 319-329

  Andry, Guy ^a   Suciu, Stefan ^b   Pratola, Danilo ^c   Sylvester, Richard ^b   Leclercq, Guy ^d   da Costa, Pierre Mendes ^a   Legros, Nicole ^d   Andry T'Hooft, Martine ^d   Verhest, Alain ^a,c   Mattheiem, Wolrad ^a   Heuson, Jean Claude ^d  

^a JULES BORDET INSTITUTE   (Belgium)

^b EORTC DATA CENTER   (Belgium)

^c ERASME HOSPITAL   (Belgium)

^d Medical Web Services   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR;

BREAST CANCER; FEMALE; HISTOLOGY; HUMAN; MAJOR CLINICAL STUDY; PROGNOSIS; SURVIVAL;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; FEMALE; HUMAN; LYMPH NODES; MASTECTOMY, MODIFIED RADICAL; MENOPAUSE; MIDDLE AGE; NEOPLASM STAGING; PROGNOSIS; RECEPTORS, ESTROGEN; RISK FACTORS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TIME FACTORS;

EID: 0024501356     PISSN: 02775379     EISSN: None     Source Type: Journal    
DOI: 10.1016/0277-5379(89)90025-4     Document Type: Article

References (79)

1. Cancer of the breast
2. Cancer of the breast
3. Oestrogen receptors and breast cancer: current status
4. Identification of breast cancer patients with high risk of early recurrence after radical mastectomy
5. Steroid hormone receptors in breast cancer treatment strategy
6. The relation between estrogen receptors and response rate to cytotoxic chemotherapy in metastatic breast cancer
7. Association between steroid hormone receptor status and disease free interval in breast cancer
8. Cancer du sein opérable: valeur pronostique du nombre des récepteurs d'estradiol
9. Possible test for selection of adjuvant systemic therapy in early cancer of the breast
10. Steroid hormone receptors in the management of human breast cancer
11. Current use of steroid hormone receptor assays in the treatment of breast cancer
12. The role of estrogen receptor status in predicting the response of carcinoma of the breast to adjuvant chemotherapy
13. Modified radical mastectomy
14. Estrogen receptors in human breast cancer
15. Histological grading and prognosis in breast cancer
16. Histological Typing of Breast Tumours
17. An overview of the EORTC Breast Cancer Cooperative Group's activities
18. Preoperative radiotherapy (RT), pre- and postoperative hormonochemotherapy (HCT) and modified radical mastectomy (S) for locally advanced breast cancer
19. Nonparametric estimation from incomplete observation
20. Comparison of survival curves
21. Design and analysis of randomized clinical trial requiring prolonged observation of each patient. II Analysis and examples
22. Regression models and life tables (with discussion)
23. Statistical Analysis
24. Number of lymph nodes examined and the prognosis of breast carcinoma
25. Steroid receptors in early breast cancer: value in prognosis
26. Estrogen receptor level and other factors in early recurrence of breast cancer
27. Estrogen receptor as an independent prognostic factor for early recurrence in breast cancer
28. Pathological review of breast lesion analyzed for estrogen receptor protein
29. Estrogen receptor protein in breast cancer as predictor of recurrence
30. Estrogen receptor concentration in 269 cases of histologically classified human breast cancer
31. Estrogen and progesterone receptors in breast carcinoma: correlations with epidemiology and pathology
32. Estradiol receptor levels in human breast carcinomas
33. The prognosis value of estrogen receptor determination in patients with primary breast cancer: an update
34. Correlation of estrogen receptor and pathologic characteristics of invasive breast cancer
35. Oestrogen receptor assay and morphology of breast cancer
36. Oestrogen receptor and survival in early breast cancer
37. Steroid receptors in human breast cancer
38. Prognostic value of estrogen receptor determination in patients with breast cancer
39. Estrogen receptor assay in primary breast cancer and early recurrence of the disease
40. Morphologic and clinical aspects of estrogen receptors in carcinoma of the breast
41. Corelation of estrophilin content of primary mammary cancer to eventual endocrine treatment
42. The prognostic significance of estrogen receptors in human breast cancer
43. Current status of estrogen receptors in human breast cancer
44. Absent estrogen receptor and decreased survival in human breast cancer
45. Estrogen receptors and breast cancer: prognostic and therapeutic implications
46. Prognostic value of estrogen receptor in primary breast cancer
47. Relationships between primary breast tumor receptor status and patient survival
48. Estrogen receptor: a prognostic factor in breast cancer
49. Relationships of estrogen receptor status to survival in breast cancer
50. Early recurrence in oestrogen receptor negative breast carcinomas
51. Implications of estrogen receptor status in primary breast carcinoma to the role of adjuvant chemotherapy in nodes negative cases
52. Estrogen receptor quantition and staging as complementary prognostic indicators in breast cancer: a study of 583 patients
53. Estrogen receptor: a prognostic factor in breast cancer
54. Estrogen receptor status as a prognostic indicator for stage I breast cancer patients
55. The relative importance of estrogen receptor analysis as a prognostic factor for recurrence or response to chemotherapy in women with breast cancer
56. The lack of relationship between estrogen receptor status and response to chemotherapy
57. Estrogen and progesterone receptor site studies as guide to the management of advanced breast cancer
58. Estrogen receptors and disease free interval: a dissenting opinion
59. Oestrogen receptors, clinical features and prognosis in stage III breast cancer
60. Steroid receptors and prognosis in operable (stage I and II) breast cancer
61. Estrogen receptors and long-term prognosis in breast cancer
62. Estrogen receptor protein of breast cancer as a predictor of recurrence
63. Significance of estrogen and progesterone receptors, disease-free interval, and site of first metastasis on survival of breast cancer patients
64. Progesterone and estrogen receptors as prognostic variables in breast cancer
65. Steroid hormone receptors and survival after first relapse in breast cancer
66. Estrogen receptor protein and its correlation to recurrent breast cancer
67. Disease-free interval and oestrogen receptor activity in tumor tissue of patients with primary breast cancer: analysis after long-term follow-up
68. Discussion
69. Relationships between oestrogen receptor content and histological grade in human primary breast tumors
70. Oestrogen receptor values and histological grade in human breast cancer
71. Predicting response to endocrine therapy in human breast cancer: a hypothesis
72. Nuclear oestrogen receptors and treatment of breast cancer
73. The use of antioestrogens tamoxifen and nafoxidine in the treatment of human breast cancer in correlation with estrogen receptor values
74. Some comments on the necessity of receptor determination in human breast cancer
75. Receptueurs des hormones stéroïdes et controˆle endocrinien des tumeurs mammaires
76. Clinical considerations of hormonal receptors in breast cancer
77. Oestrogen receptors, site of metastatic disease and survival in recurrent breast cancer